Literature DB >> 8331179

Sequential reactivity of serum against cyst antigens in Toxoplasma infection.

G Woodison1, A H Balfour, J E Smith.   

Abstract

AIMS: To compare the recognition of Toxoplasma gondii tachyzoites and cysts by sera, from 10 patients.
METHODS: Recognition of antigens from purified tachyzoites (RH strain) and bradyzoites (18691 strain) was compared using western immunoblotting. Sequential serum samples from 10 patients and one laboratory acquired RH infection were used.
RESULTS: Recognition of cyst antigens was relatively low and occurred late in infection. The two stages were antigenically distinct with only a few shared bands.
CONCLUSION: Immunological recognition of the cystic stage of T gondii is low. This implies that either cysts are poorly immunogenic or that cyst antigen is not available for processing and presentation.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8331179      PMCID: PMC501293          DOI: 10.1136/jcp.46.6.548

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  14 in total

1.  Identification of the dominant cyst antigens of Toxoplasma gondii.

Authors:  G Woodison; J E Smith
Journal:  Parasitology       Date:  1990-06       Impact factor: 3.234

2.  Western blot analysis of the antibody response of patients with AIDS and toxoplasma encephalitis: antigenic diversity among Toxoplasma strains.

Authors:  L M Weiss; S A Udem; H Tanowitz; M Wittner
Journal:  J Infect Dis       Date:  1988-01       Impact factor: 5.226

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

5.  Separation of Isospora (Toxoplasma) gondii cysts and cystozoites from mouse brain tissue by continuous density-gradient centrifugation.

Authors:  A W Cornelissen; J P Overdulve; J M Hoenderboom
Journal:  Parasitology       Date:  1981-08       Impact factor: 3.234

6.  Examination of ovine foetal fluid for antibodies to Toxoplasma gondii by the dye test and an indirect immunofluorescence test specific for IgM.

Authors:  D Hunter; P Chadwick; A H Balfour; J B Bridges
Journal:  Br Vet J       Date:  1982 Jan-Feb

7.  Analysis of Toxoplasma gondii antigens recognized by human sera obtained before and after acute infection.

Authors:  I Potasman; F G Araujo; G Desmonts; J S Remington
Journal:  J Infect Dis       Date:  1986-10       Impact factor: 5.226

8.  Toxoplasmic encephalitis in patients with acquired immune deficiency syndrome.

Authors:  B J Luft; R G Brooks; F K Conley; R E McCabe; J S Remington
Journal:  JAMA       Date:  1984-08-17       Impact factor: 56.272

9.  Cerebral toxoplasmosis complicating the acquired immune deficiency syndrome: clinical and neuropathological findings in 27 patients.

Authors:  B A Navia; C K Petito; J W Gold; E S Cho; B D Jordan; R W Price
Journal:  Ann Neurol       Date:  1986-03       Impact factor: 10.422

10.  Antigenic differences between endozoites and cystozoites of Toxoplasma gondii.

Authors:  M N Lunde; L Jacobs
Journal:  J Parasitol       Date:  1983-10       Impact factor: 1.276

View more
  3 in total

Review 1.  Laboratory-acquired parasitic infections from accidental exposures.

Authors:  B L Herwaldt
Journal:  Clin Microbiol Rev       Date:  2001-10       Impact factor: 26.132

2.  Improved diagnosis of reactivated toxoplasmosis.

Authors:  D Ashburn; M M Davidson; A W Joss; T H Pennington; D O Ho-Yen
Journal:  Mol Pathol       Date:  1998-04

3.  Serological reactivity against cyst and tachyzoite antigens of Toxoplasma gondii determined by FAST-ELISA.

Authors:  Y W Zhang; A Fraser; A H Balfour; T G Wreghitt; J J Gray; J E Smith
Journal:  J Clin Pathol       Date:  1995-10       Impact factor: 3.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.